Main Session
Sep
29
SS 42 - Advanced Lung Cancer and Drug Combinations
276 - Pirfenidone for Reducing Radiation-Induced Lung Injury in Lung Cancer Patients with Prior Receipt of Immune Checkpoint Inhibitors: A Single-Arm, Multicenter, Open-Label, Phase 2 Trial
Presenter(s)
Chi Lin, MD, PhD, MS - University of Nebraska Medical Center, Omaha, NE